1Kikkawa R, Koya D, Haneda M. Progression of diabetic nephropathy[J]. Am J Kidney Dis, 2003,41 (3 Suppl 1 ) : 19- 21.
2Fioretto P,Steffes M W,Sutherland D E,et al. Reversal of lesions of diabetic nephropathy after pancreas transplantation[J]. N Engl J Med,1998,339(2) :69-75.
3Brownlee M, Cerami A,Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications[J]. N Engl J Med, 1988,318(20) :1315-1321.
4Yamagishi S, TakeuchiM, Inagaki Y, et al. Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy [J]. Int J Clin Pharmacol Res,2003,23(4) : 129-134.
5Kumar D,Robertson S,Bum K D. Evidence of apoptosis in human diabetic kidney[J]. Mol Cell Biochem,2004,259(1-2):67-70.
6Sakurai K,Cominacini L,Garbin U,et al. Induction of endothelin-1 production in endothelial cells via co-operative action between CD40 and lectin - like oxidized LDL receptor( LOX-1 )[J]. J Cardiovasc Pharmacol, 2004,44 ( 11 ):S173-S180.
7Prabhakk S S. Role of nitric oxide in diabetic nephropathy[J]. Curr Diab Rep,2005,5(6) :449-454.
8Matsumoto K, Nakamura T. Hepatocyte growth factor, renotropic role and potential therapeutics for renal diseases[J]. Kidney Int, 2001,59(6) : 2023-2038.
9Tuttle K R. Liking metabolism and immunology: diabetic nephropathy is an inflammatory disease[J]. J Am Soc Nephrol, 2005,16(6) : 1537-1538.
10Haslinger B, Mand-weber glucose concentration S, Sellmager A, et al. Effect of high on the synthesis of monocyte chemoattractant protein-1 in human perineal mesothelial cells: involvement of protein kinase C[J]. Nephron, 2001,87 (4):346-351.
